Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-26T00:54:37.207Z Has data issue: false hasContentIssue false

Nomifensine for Side-Effects of Depot Neuroleptics

Published online by Cambridge University Press:  29 January 2018

G. W. Hanks*
Affiliation:
Sir Michael Sobell House, The Churchill Hospital, Headington, Oxford OX3 7LJ
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Copyright
Copyright © The Royal College of Psychiatrists 

References

Bedard, P., Parkes, J. D. & Marsden, C. D. (1977) Nomifensine in Parkinson's disease. British Journal of Clinical Pharmacology, 4, 187–90.CrossRefGoogle Scholar
Capstick, N. & Pudney, H. (1976) A comparative trial of orphenadrine and tofenacin in the control of depression and extrapyramidal side-effects associated with fluphenazine decanoate therapy. Journal of International Medical Research, 4, 435–40.Google Scholar
Hanks, G. W. & Park, D. M. (1981) Nomifensine. In Research Progress in Parkinson's Disease (fids. Clifford Rose, F. and Capildeo, R.). Pp 345–50. Tunbridge Wells: Pitman Medical Google Scholar
Johnson, D. A. W. (1981) Studies of depressive symptoms in schizophrenia. III. A double blind trial of orphenadrine against placebo. British Journal of Psychiatry, 139, 96–7.Google Scholar
Onuaguluchi, G. (1963) Assessment of drug therapy in parkinsonism. British Medical Journal, i, 443–48.Google Scholar
Park, D. M., Findley, L. J., Hanks, G. & Sandler, M. (1981) Nomifensine: effect in parkinsonian patients not receiving levodopa. Journal of Neurology, Neurosurgery and Psychiatry, 44, 352–4.CrossRefGoogle Scholar
Teychenne, P. F., Park, D. M., Findley, L. J., Rose, F. C. & Calne, D. B. (1976) Nomifensine in parkinsonism. Journal of Neurology, Neurosurgery and Psychiatry, 39, 1219–21.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.